共 42 条
Collaborative Cohort Study of an Intervention to Reduce Ventilator-Associated Pneumonia in the Intensive Care Unit
被引:156
作者:
Berenholtz, Sean M.
[1
,6
]
Pham, Julius C.
Thompson, David A.
Needham, Dale M.
Lubomski, Lisa H.
Hyzy, Robert C.
[2
]
Welsh, Robert
[3
]
Cosgrove, Sara E.
Sexton, J. Bryan
Colantuoni, Elizabeth
Watson, Sam R.
[4
]
Goeschel, Christine A.
[5
,6
]
Pronovost, Peter J.
[5
,6
]
机构:
[1] Johns Hopkins Univ, Qual & Safety Res Grp, Sch Med, Baltimore, MD 21231 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] William Beaumont Hosp, Royal Oak, MI 48072 USA
[4] Michigan Hlth & Hosp Assoc Keystone Ctr, Lansing, MI USA
[5] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21231 USA
[6] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21231 USA
基金:
美国国家卫生研究院;
美国医疗保健研究与质量局;
关键词:
QUALITY IMPROVEMENT;
NOSOCOMIAL INFECTIONS;
IMPACT;
BUNDLE;
SAFETY;
GUIDELINE;
MORTALITY;
OUTCOMES;
DEFECTS;
PROGRAM;
D O I:
10.1086/658938
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
OBJECTIVE. To evaluate the impact of a multifaceted intervention on compliance with evidence-based therapies and ventilator-associated pneumonia (VAP) rates. DESIGN. Collaborative cohort before-after study. SETTING. Intensive care units (ICUs) predominantly in Michigan. INTERVENTIONS. We implemented a multifaceted intervention to improve compliance with 5 evidence-based recommendations for mechanically ventilated patients and to prevent VAP. A standardized CDC definition of VAP was used and maintained at each site, and data on the number of VAPs and ventilator-days were obtained from the hospital's infection preventionists. Baseline data were reported and postimplementation data were reported for 30 months. VAP rates (in cases per 1,000 ventilator-days) were calculated as the proportion of ventilator-days per quarter in which patients received all 5 therapies in the ventilator care bundle. Two interventions to improve safety culture and communication were implemented first. RESULTS. One hundred twelve ICUs reporting 3,228 ICU-months and 550,800 ventilator-days were included. The overall median VAP rate decreased from 5.5 cases (mean, 6.9 cases) per 1,000 ventilator-days at baseline to 0 cases (mean, 3.4 cases) at 16-18 months after implementation (P < .001) and 0 cases (mean, 2.4 cases) at P < .001 28-30 months after implementation (P < .001). Compared to baseline, VAP rates decreased during all observation periods, with incidence rate ratios of 0.51 (95% confidence interval, 0.41-0.64) at 16-18 months after implementation and 0.29 (95% confidence interval, 0.24-0.34) at 28-30 months after implementation. Compliance with evidence-based therapies increased from 32% at baseline to 75% at 16-18 months after implementation (P < .001) and 84% at 28-30 months after implementation (P < .001). CONCLUSIONS. A multifaceted intervention was associated with an increased use of evidence-based therapies and a substantial (up to 71%) and sustained (up to 2.5 years) decrease in VAP rates. Infect Control Hosp Epidemiol 2011; 32(4): 305-314
引用
收藏
页码:305 / 314
页数:10
相关论文